🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Cohort Study for Atrial Fibrillation Risk Stratification

Recruitingn/aAges 18 Years - 85 YearsAllUniversitätsklinikum Hamburg-Eppendorf
NCT05442970 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

AFHRI is planned as a prospective, single-center cohort study in patients at high risk of AF.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age 18 to 85 years; * Personally signed informed consent Exclusion Criteria: * Insufficient knowledge of the German language, in order to understand study documents and computer assisted interview without translation; * Physical or psychological incapability to cooperate in the investigations
💊

What it tests

  • Not listed
📍

Where

1 site
Department of Cardiology, University Medical Center Hamburg-Eppendorf
Hamburg, Germany
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy